Form 8.3 - Dechra Pharmaceuticals plc

RNS Number : 8829Z

Barclays PLC

16 January 2024

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				DECHRA PHARMACEUTICALS PLC
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				15 Jan 2024
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				1p ordinary
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			7,412,711	6.51%	591,073	0.52%
(2)	Cash-settled derivatives:
	and/or controlled:			549,639	0.48%	7,337,178	6.44%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			0	0.00%	0	0.00%

	TOTAL:			7,962,350	6.99%	7,928,251	6.96%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
1p ordinary		Purchase		341,877		38.6600 GBP
1p ordinary		Purchase		300,000		38.6638 GBP
1p ordinary		Purchase		224,447		38.6604 GBP
1p ordinary		Purchase		8,000		38.6629 GBP
1p ordinary		Purchase		5,880		38.6749 GBP
1p ordinary		Purchase		2,446		38.6580 GBP
1p ordinary		Purchase		2,337		38.6740 GBP
1p ordinary		Purchase		1,848		38.6675 GBP
1p ordinary		Purchase		1,524		38.6800 GBP
1p ordinary		Purchase		1,134		38.6709 GBP
1p ordinary		Purchase		928		38.6700 GBP
1p ordinary		Purchase		36		38.6761 GBP
1p ordinary		Sale		201,358		38.6600 GBP
1p ordinary		Sale		6,778		38.6400 GBP
1p ordinary		Sale		5,229		38.6499 GBP
1p ordinary		Sale		2,046		38.6800 GBP
1p ordinary		Sale		1,345		38.6700 GBP
1p ordinary		Sale		753		38.6680 GBP
1p ordinary		Sale		669		38.6561 GBP
1p ordinary		Sale		490		38.6731 GBP
1p ordinary		Sale		129		38.6500 GBP

(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
1p ordinary		SWAP		Closing Short		1	38.6600 GBP
1p ordinary		SWAP		Decreasing Short		39	38.6700 GBP
1p ordinary		SWAP		Decreasing Short		152	38.6961 GBP
1p ordinary		SWAP		Decreasing Short		669	38.6561 GBP
1p ordinary		SWAP		Decreasing Short		1,262	38.6641 GBP
1p ordinary		CFD		Decreasing Short		1,904	38.6800 GBP
1p ordinary		SWAP		Decreasing Short		1,991	38.6632 GBP
1p ordinary		SWAP		Decreasing Short		5,229	38.6499 GBP
1p ordinary		SWAP		Decreasing Short		50,740	38.6573 GBP
1p ordinary		SWAP		Increasing Short		36	38.6760 GBP
1p ordinary		SWAP		Increasing Short		642	38.6715 GBP
1p ordinary		SWAP		Increasing Short		1,134	38.6709 GBP
1p ordinary		CFD		Increasing Short		1,626	38.6600 GBP
1p ordinary		SWAP		Increasing Short		1,848	38.6675 GBP
1p ordinary		SWAP		Increasing Short		2,337	38.6740 GBP
1p ordinary		SWAP		Increasing Short		8,000	38.6629 GBP
1p ordinary		SWAP		Increasing Short		11,179	38.6800 GBP
1p ordinary		SWAP		Increasing Short		260,980	38.6600 GBP
1p ordinary		SWAP		Increasing Short		480,737	38.6638 GBP

(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates


(ii)	Exercising
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit


(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)

4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				16 Jan 2024
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETEADFKFFDLEFA